The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.00
Bid: 53.00
Ask: 55.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.774%)
Open: 54.00
High: 54.00
Low: 54.00
Prev. Close: 54.00
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Calyx Group PLC

30 May 2007 11:01

BlackRock Group30 May 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) BlackRock GroupCompany dealt in Calyx GroupClass of relevant security to which the €0.10 ordinary sharesdealings being disclosed relate (Note 2)Date of dealing 29th May 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 1,200,000 1.72%(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 1,200,000 1.72% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 100,000 GBP 0.99 (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name,e.g. Writing, Number of Exercise Type, e.g. Expiry Option moneypaidcall option selling, securities to which price American, date /received per purchasing, the option relates European etc. unit (Note 5) varying etc. (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. None.............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 30th May, 2007Contact name Thomas HoneTelephone number 020 7743 2098If a connected EFM, name of offeree/offeror with which N/AconnectedIf a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company
15th Oct 20219:33 amRNSPDMR Dealing
12th Oct 20217:00 amRNSTrading Update
7th Sep 20217:00 amRNSAward of Options
19th Aug 20215:05 pmRNSResult of AGM
19th Aug 20217:00 amRNSAGM Statement
4th Aug 20214:34 pmRNSHolding(s) in Company
15th Jul 20212:53 pmRNSDirector Dealing
28th Jun 20217:00 amRNSNotice of AGM and Posting of Annual Report
16th Jun 20214:26 pmRNSPDMR Dealing
25th May 20217:00 amRNSFY21 Final Results
17th May 20217:00 amRNSNotice of Results and Investor Presentation
15th Apr 202112:31 pmRNSPDMR Shareholding
1st Apr 20214:05 pmRNSPDMR/PCA Dealing
24th Mar 20214:14 pmRNSPDMR Dealing
16th Feb 20217:00 amRNSTrading Update
1st Feb 20213:53 pmRNSPDMR Dealing
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20209:00 amRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSInterim Results
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
12th Oct 20206:10 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.